Effect of pomegranate peel polyphenol gel on cutaneous wound healing in alloxan-induced diabetic rats

Chinese Medical Journal

Volumn 126, Issue 9, 2013, Pages 1700-1706

  Yan, Huan ^a   Peng, Ke Jun ^b   Wang, Qiu Lin ^b   Gu, Zheng Yi ^d   Lu, Yao Qin ^c   Zhao, Jun ^d   Xu, Fang ^d   Liu, Yi Lun ^b   Tang, Ying ^b   Deng, Feng Mei ^b   Zhou, Peng ^b   Jin, Jia Gui ^b   Wang, Xin Chun ^a  

^a SHIHEZI UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

^c Tianshan Center for Disease Control and Prevention   (China)

^d Xinjiang Institute of Materia Medica   (China)

Author keywords

Diabetes; Pomegranate peel polyphenol; Wound healing

Indexed keywords

ALLOXAN; COLLAGEN FIBER; EPIDERMAL GROWTH FACTOR; HYDROXYPROLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYPHENOL; POMEGRANATE EXTRACT; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIZATION; EUTHANASIA; GLUCOSE BLOOD LEVEL; HISTOLOGY; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INJURY; VASCULARIZATION; WOUND CLOSURE; WOUND HEALING;

ALLOXAN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GELS; HYDROXYPROLINE; MALE; NITRIC OXIDE; POLYPHENOLS; PUNICACEAE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84876939624     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122728     Document Type: Article

References (34)

1. Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg 2003; 30: 37-45.
2. Laitiff AA, Teoh SL, Das S. Wound healing in diabetes mellitus: traditional treatment modalities. Clin Ter 2010; 161: 359-364.
3. Carvalho Pde T, Silva IS, Reis FA, Perreira DM, Aydos RD. Influence of ingaalp laser (660 nm) on the healing of skin wounds in diabetic rats. Acta Cir Bras 2010; 25: 71-79.
4. Galeano M, Altavilla D, Cucinotta D, Russo GT, Calò M, Bitto A, et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004; 53: 2509-2517.
5. Yavuz D, Tuǧtepe H, Cetinel S, Uyar S, Kaya H, Haklar G, et al. Collagen ultrastructure and TGF-beta1 expression preserved with aminoguanidine during wound healing in diabetic rats. Endocr Res 2005; 31: 229-243.
6. Biswas A, Bharara M, Hurst C, Gruessner R, Armstrong D, Rilo H. Use of sugar on the healing of diabetic ulcers: a review. J Diabetes Sci Technol 2010; 4: 1139-1145.
7. Singh AP, Singh AJ, Singh N. Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats. Indian J Pharmacol 2011; 43: 551-556.
8. Tang PC, Rao SR, Tang YM. Advance of the extraction of pomegranate peel polyphenol and its activity. J Xihua Univ (Nat Sci Edi) (Chin) 2011; 30: 98-102.
9. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000; 71: 1062-1076.
10. Gracious Ross R, Selvasubramanian S, Jayasundar S. Immunomodulatory activity of Punica granatum in rabbits--a preliminary study. J Ethnopharmacol 2001; 78: 85-87.
11. Navarro V, Villarreal ML, Rojas G, Lozoya X. Antimicrobial evaluation of some plants used in Mexican traditional medicine for the treatment of infectious diseases. J Ethnopharmacol 1996; 53: 143-147.
12. Tzulker R, Glazer I, Bar-Ilan I, Holland D, Aviram M, Amir R. Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. J Agric Food Chem 2007; 55: 9559-9570.
13. Murthy KN, Reddy VK, Veigas JM, Murthy UD. Study on wound healing activity of Punica granatum peel. J Med Food 2004; 7: 256-259.
14. Yan H, Gu ZY, Chen XJ, Liu XL, Ma JH, Pang SB. Preparation and quality control of pomegranate polyphenols gel. Chin J Exp Tradit Med Form (Chin) 2011; 17: 4-6.
15. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341:738-746.
16. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007; 25: 9-18.
17. -/- mice. Am J Pathol 2001; 159: 457-463.
18. Yang L, Chan T, Demare J, Iwashina T, Ghahary A, Scott PG, et al. Healing of burn wounds in transgenic mice overexpressing transforming growth-β1 in the epidermis. Am J Pathol 2001; 159: 2147-2157.
19. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-1743.
20. Bitar MS, Labbad ZN. Transforming growth factor-β and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res 1996; 61: 113-119.
21. Thangarajah H, Yao D, Chang EI, Shi Y, Jazayeri L, Vial IN, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 2009; 106: 13505-13510.
22. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-145.
23. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006; 580: 2879-2887.
24. Santos SC, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y, et al. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 2007; 313: 1561-1574.
25. Coulombe PA. Wound epithelialization: accelerating the pace of discovery. J Invest Dermatol 2003; 121: 219-230.
26. Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 1990; 11: 418-442.
27. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993; 165: 728-737.
28. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C δ signaling pathway. J Invest Dermatol 2004; 122: 1390-1398.
29. Luo JD, Wang YY, Fu WL, Wu J, Chen AF. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 2004; 110: 2484-2493.
30. Yamasaki K, Edington HD, McClosky C, Tzeng E, Lizonova A, Kovesdi I, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998; 101: 967-971.
31. Donnini S, Ziche M. Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid Redox Signal 2002; 4: 817-823.
32. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J Clin Invest 2007; 117: 1249-1259.
33. Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep 2005; 57 Suppl: S108-S119.
34. Schwentker A, Vodovotz Y, Weller R, Billiar TR. Nitric oxide and wound repair: role of cytokines? Nitric Oxide 2002; 7: 1-10.